These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12720216)

  • 1. Minor histocompatibility antigen-specific cytotoxic T lymphocytes generated with dendritic cells from DLA-identical littermates.
    Georges GE; Lesnikova M; Storb R; Yunusov M; Little MT; Nash RA
    Biol Blood Marrow Transplant; 2003 Apr; 9(4):234-42. PubMed ID: 12720216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minor histocompatibility antigens on canine hemopoietic progenitor cells.
    Weber M; Lange C; Günther W; Franz M; Kremmer E; Kolb HJ
    J Immunol; 2003 Jun; 170(12):5861-8. PubMed ID: 12794111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
    Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
    Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Minor histocompatibility antigen-specific, leukemia-reactive cytotoxic T cell clones can be generated in vitro without in vivo priming using chronic myeloid leukemia cells as stimulators in the presence of alpha-interferon.
    Faber LM; van Luxemburg-Heijs SA; Rijnbeek M; Willemze R; Falkenburg JH
    Biol Blood Marrow Transplant; 1996 Feb; 2(1):31-6. PubMed ID: 9078352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adoptive immunotherapy in canine mixed chimeras after nonmyeloablative hematopoietic cell transplantation.
    Georges GE; Storb R; Thompson JD; Yu C; Gooley T; Bruno B; Nash RA
    Blood; 2000 May; 95(10):3262-9. PubMed ID: 10807798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of graft-versus-tumor responses in melanoma patients after allogeneic peripheral blood stem cell transplantation.
    Kurokawa T; Fischer K; Bertz H; Hoegerle S; Finke J; Mackensen A
    Int J Cancer; 2002 Sep; 101(1):52-60. PubMed ID: 12209588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adoptive immunotherapy against kidney targets in dog-leukocyte antigen-identical mixed hematopoietic canine chimeras.
    Junghanss C; Takatu A; Little MT; Maciej Zaucha J; Zellmer E; Yunusov M; Sale G; Georges GE; Storb R
    Transplantation; 2003 Feb; 75(3):268-74. PubMed ID: 12589144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adoptive immunotherapy against allogeneic kidney grafts in dogs with stable hematopoietic trichimerism.
    Graves SS; Hogan WJ; Kuhr C; Diaconescu R; Harkey M; Sale GE; Stone B; Georges GE; Storb R
    Biol Blood Marrow Transplant; 2008 Nov; 14(11):1201-8. PubMed ID: 18940673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recipient-specific donor cytotoxic T lymphocytes enhance engraftment of unrelated, DLA non-identical canine marrow.
    Schwarzinger I; Raff RF; Flowers M; Niederwieser D; Graham T; Shulman H; Appelbaum FR; Schuening F; Storb R
    Bone Marrow Transplant; 1994 Mar; 13(3):303-9. PubMed ID: 8199572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic T-lymphocyte-defined human minor histocompatibility antigens with a restricted tissue distribution.
    Warren EH; Greenberg PD; Riddell SR
    Blood; 1998 Mar; 91(6):2197-207. PubMed ID: 9490709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FLT3 ligand promotes engraftment of allogeneic hematopoietic stem cells without significant graft-versus-host disease.
    Yunusov MY; Georges GE; Storb R; Moore P; Hagglund H; Affolter V; Lesnikova M; Gass MJ; Little MT; Loken M; McKenna H; Storer B; Nash RA
    Transplantation; 2003 Apr; 75(7):933-40. PubMed ID: 12698076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engraftment of DLA-haploidentical marrow with ex vivo expanded, retrovirally transduced cytotoxic T lymphocytes.
    Georges GE; Storb R; Bruno B; Brodie SJ; Thompson JD; Taranova AG; Zaucha JM; Little MT; Zellmer E; Moore PF; Gooley T; Sale G; Kiem HP; Sandmaier BM; Lyons RM; Nash RA
    Blood; 2001 Dec; 98(12):3447-55. PubMed ID: 11719387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effector cells derived from host CD8 memory T cells mediate rapid resistance against minor histocompatibility antigen-mismatched allogeneic marrow grafts without participation of perforin, Fas ligand, and the simultaneous inhibition of 3 tumor necrosis factor family effector pathways.
    Zimmerman Z; Shatry A; Deyev V; Podack E; Mammolenti M; Blazar BR; Yagita H; Levy RB
    Biol Blood Marrow Transplant; 2005 Aug; 11(8):576-86. PubMed ID: 16041307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple minor histocompatibility antigen disparities between a recipient and four HLA-identical potential sibling donors for bone marrow transplantation.
    Marijt EA; Veenhof WF; Goulmy E; Kluck PM; Brand A; Willemze R; van Rood JJ; Falkenburg JH
    Hum Immunol; 1993 Aug; 37(4):221-8. PubMed ID: 8300407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of CD4+ donor lymphocytes induces the expansion of CD8+ donor T cells with cytolytic activity directed against recipient hematopoietic cells.
    Zorn E; Wang KS; Hochberg EP; Canning C; Alyea EP; Soiffer RJ; Ritz J
    Clin Cancer Res; 2002 Jul; 8(7):2052-60. PubMed ID: 12114403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
    Mutis T; Ghoreschi K; Schrama E; Kamp J; Heemskerk M; Falkenburg JH; Wilke M; Goulmy E
    Biol Blood Marrow Transplant; 2002; 8(8):412-9. PubMed ID: 12234166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth inhibition of clonogenic leukemic precursor cells by minor histocompatibility antigen-specific cytotoxic T lymphocytes.
    Falkenburg JH; Goselink HM; van der Harst D; van Luxemburg-Heijs SA; Kooy-Winkelaar YM; Faber LM; de Kroon J; Brand A; Fibbe WE; Willemze R
    J Exp Med; 1991 Jul; 174(1):27-33. PubMed ID: 2056279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of minor histocompatibility antigen HA-1-specific cytotoxic T cells restricted by nonself HLA molecules: a potential strategy to treat relapsed leukemia after HLA-mismatched stem cell transplantation.
    Mutis T; Blokland E; Kester M; Schrama E; Goulmy E
    Blood; 2002 Jul; 100(2):547-52. PubMed ID: 12091347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific tolerance and immunocompetence in haploidentical, but not in completely allogeneic, canine chimeras treated with methotrexate and cyclosporine.
    Deeg HJ; Severns E; Raff RF; Sale GE; Storb R
    Transplantation; 1987 Nov; 44(5):621-32. PubMed ID: 2961110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.